Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Nicholas DeHaan
Institutions:
Cytokinetics (United States),
Nurix (United States)
Observed institutions:
Cytokinetics (United States),
Nurix (United States)
OpenAlex ID:
A5104723595
AI is a viable alternative to high throughput screening: a 318-target study
2024
·
The Atomwise AIMS Program
, Izhar Wallach
, et al.
·
Scientific Reports
·
144
Author Correction: AI is a viable alternative to high throughput screening: a 318-target study
2024
·
The Atomwise AIMS Program
, Izhar Wallach
, et al.
·
Scientific Reports
·
3
PDF
Show more works
View as search
Works count:
2
Citation count:
147
H-index:
2
I10-index:
1
Year
Topic
Type
